Dystrophic heart failure blocked by membrane sealant poloxamer (Q46604988)

23 December 2017

title

Dystrophic heart failure blocked by membrane sealant poloxamer (English)

1 reference

23 December 2017

0 references

Soichiro Yasuda

1

1 reference

23 December 2017

DeWayne Townsend

2

1 reference

23 December 2017

Daniel E Michele

3

1 reference

23 December 2017

Elizabeth G Favre

4

1 reference

23 December 2017

Sharlene M Day

5

1 reference

23 December 2017

Joseph M Metzger

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

17 July 2005

1 reference

23 December 2017

number of pages

5

1 reference

inferred from page(s)

published in

Nature

1 reference

23 December 2017

volume

436

1 reference

23 December 2017

issue

7053

1 reference

23 December 2017

page(s)

1025-1029

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/nature03844

exact match

0 references

cites work

Cardiomyopathy in muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

The heart in human dystrophinopathies

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Mechanical function of dystrophin in muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Lipid corralling and poloxamer squeeze-out in membranes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Pharmaceutical therapies for sealing of permeabilized cell membranes in electrical injuries

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Increased calcium influx in dystrophic muscle

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Defective membrane repair in dysferlin-deficient muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Myoferlin, a candidate gene and potential modifier of muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Pharmacokinetics of RheothRx injection in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Muscular dystrophies and the dystrophin-glycoprotein complex

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

A novel method to study contraction characteristics of a single cardiac myocyte using carbon fibers

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03844

7 January 2021

Identifiers

DOI

10.1038/NATURE03844

1 reference

23 December 2017

Dimensions Publication ID

0 references

1 reference

23 December 2017